chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse practitioner referring to an 18 year old female patient with allergic rhinitis. The patient's medical history included eczema and childhood asthma. Drug reactions or allergies were unknown.  Concomitant medications were not unknown by reporter. On 18-MAY-2017 the patient was vaccinated with a dose of VARIVAX (lot # M045204, expiration date 11-NOV-2018; dose and site of administration unknown) subcutaneously for "vaccination".  Other suspect therapies included sterile diluent (STERILE DILUENT). Soon after the patient had left, on 18-MAY-2017, the patient experienced shaking, had hives (unspecified location) and was having trouble breathing. The patient returned to office approximately 20 minutes after administration of VARIVAX and was having a "severe allergic reaction". The nurse practitioner reported that she gave the patient prednisone (manufacturer unknown), oxygen, and an unspecified nebulizer as treatment for the severe allergic reaction on 18-MAY-2017. Once the patient was stabilized (on 18-MAY-2017), the nurse practitioner called an ambulance and the patient was transported to the emergency room. The nurse practitioner reported that the patient received unspecified treatment while in the emergency room and was not admitted to hospital. The patient was discharged later that day (18-MAY-2017). The outcome of the event was reported as recovered (on an unspecified date in 2017). Causality assessment was not provided. No product quality complaint (PQC) was involved. "Severe allergic reaction" was considered to be life threatening by the reporting nurse practitioner. Additional information has been requested.
employee presented to the ER with fever , chills and Headaches ,Vomiting  and cough
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced NAUSEA (Nausea), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea). At the time of the report, NAUSEA (Nausea), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient administered Moderna mRNA vaccine despite no approval/EUA - Should have been given Pfizer vaccine  Patient tolerated vaccine
Chest pains shortness of breath nausea and anxiety; Chest pains shortness of breath nausea and anxiety; Chest pains shortness of breath nausea and anxiety; Chest pains shortness of breath nausea and anxiety; This is a spontaneous report from a contactable consumer (patient) or other non hcp.  A 47-years-old female patient (Non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Qw0168 and expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 15May2021 (age at vaccination: 47) at 09:45 as dose 2 single for covid-19 immunisation. Medical history included Chronic migraines high blood pressure, fibromyalgia & mistrial valve prolapse. The patient had no known allergies. Concomitant medications were not reported. The patient previously received dose 1 of bnt162b2 on 24APR2021 at 09:45 AM for covid-19 immunisation (Lot number: Ew0171, Vaccine location: Left arm). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced Chest pains shortness of breath nausea and anxiety on 25May2021. The patient received treatment for the events (Sent home from work to recover). No seriousness criteria reported. Outcome of all the events was recovering.  Follow-up attempts are completed. No further information is expected.
bleeding; she presented swelling in her ovaries and waist; severe pain; the presence of "a ball" in her right hand; internal pressure in her left eye; she presented swelling in her ovaries and waist; This is a spontaneous report from a contactable consumer. A female patient of unspecified age received first dose of BNT162B2 on 05Jun2021 1:45 pm at single dose for COVID-19 immunization. Medical history was not reported and concomitant medications were none. Patient was given "two little bottles"). Patient has had the same symptoms (swelling in ovaries and waist, severe pain, the presence of "a ball" in her right hand and internal pressure in left eye) but she also had bleeding after receiving "two little bottles" of the vaccine. Patient should have received her second dose in July. The outcome of events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
pt recv vax 3NOV97 & that same day pt exp hives & swelling over the neck, arms, axilla;26NOV97 f/u tx w/EPI & DPH;had good results from EPI but hives returned about 2hr later;told to cont DPH;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2 NOS), in Jan2023 as dose number unknown, single (Lot number: AS7170B) at the age of 61 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Pre-diabetic" (unspecified if ongoing), notes: Other medical history: pre-diabetic; "Asthma" (unspecified if ongoing), notes: Other medical history: asthma. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures included Paxlovid from  08Aug2023 to 13Aug2023 were taken as a result of drug ineffective, covid-19.
I noticed a very enlarged lymph node on my neck. I have since had an ultrasound and blood work-waiting on results. Lymph node is still enlarged.
Client was assessed by EMD due to chief complaint of tingling of the left hand and fingers after receiving the vaccine.  Client states the sensation (tingling) has gone away.  Client was cleared by EMT to go home.
pt recv vax DEC97 & w/in 2 days had no eyelashes;follow up from responsible MD reveals 19JAN98 6 days p/vax pt mom called MD & stated child lost eyelashes & eyes puffy but not bad;
No adverse effects or symptoms following administration; VARIVAX was administered following temperature excursion.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant medications, and drug reactions or allergies was not provided by the reporter.  On 15-MAY-2022, the vaccine underwent a temperature excursion of 6 Fahrenheit (F) during 7 minutes. There was no previous temperature excursion. Following the temperature excursion, on 27-MAY-2022, the patient received a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL, lot# U020244 with expiration date 28-JUN-2023 (strength and route of administration was not reported), administered for prophylaxis. No adverse effects or symptoms following administration.; Sender's Comments:  US-009507513-2206USA001318: US-009507513-2206USA001331: US-009507513-2206USA001347: US-009507513-2206USA001555: US-009507513-2206USA001558: US-009507513-2206USA001561:
13 days after receiving first dose I had a Pulmonary Emoblism in my left lung
NO adverse event(s) or treatment noted at this time.  0.5ml dose given vs 0.25 ml dose for 1st Booster.
Moderna COVID-19 Vaccine: Higher-than-authorized dose volume administered Patient received 0.5 ml dose of Moderna Covid Vaccine on 1/11/21 and a 1 ml dose of Moderna Covid vaccine on 6/1/21.
Patient developed fever, cold sweats, chills, and headaches the night after receiving anthrax vaccine in the morning. Presented 2 cm erythematous, warm, mildly raised lesion at the site of injection.
arm was sore to touch; swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore to touch) and LYMPHADENOPATHY (swollen lymph node) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included QUETIAPINE FUMARATE (SEROQUEL) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was sore to touch) and LYMPHADENOPATHY (swollen lymph node). On 17-Mar-2021, PAIN IN EXTREMITY (arm was sore to touch) and LYMPHADENOPATHY (swollen lymph node) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment drugs were reported      This case was linked to US-MODERNATX, INC.-MOD-2021-083469 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083469:cross linked to Dose 2
Injection site sore immediately swelled and turned black within 2 hours. Knees and elbow became sore. Left knee never recovered. Swelled and sore for 2 weeks. 12/3/06 received Cortisone shot, better today.
Patient present to ED on 4/21/21 due to severe hypokalemia, hyponatremia, bradycardia and hypotension. Patient PMHx of multiple abdominal surgeries with near total colectomy and functional intestinal disorder. It was not sure if this was a vaccine related ADR. Report for record keeping.
you recently had Covid; you recently had Covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "you recently had Covid".  Additional information: The reporter tried to use the form at # but when he entered his employee ID for validation it kept kicking him back to the main screen and asking if this was about the COVID-19 Vaccine in an endless loop. Last night his mother told him that her oncologist from (Clinic name withheld) told her she should not get the COVID vaccine and sent her the following: Dr. (Name withheld) said: 1. "Because you recently had Covid, you are both better vaccinated that you would be with the vaccine. 2. Increasing doses of the Covid vaccine, leads to increasing the risk for more severe side effects, including immunosuppression, blood clots, secondary cancers, and many other things. 3. This iteration of the vaccine was approved and released without human trials. This time it was based on the results from 7 rabbits, rather than just 4 with the bivalent. We do not know if it will be effective, but likely it will be just as worthless as the bivalent vaccine and the booster before it were. 4. The current administration, FDA and CDC have an undoubtable record now (with a complicit press) of blatant deception regarding these vaccines. 5. The pharmacist is under- and potentially mis-informed. I ascribe no ill intent to him, as he is simply parroting governmental directives from untrustworthy sources. 6. Yes, you both have several of the factors that place you in the highest risk group, but as I stated in #1 you are already more potentently immunized, without the additional risk of short and long term side effects. You will of course have to make your own decision, but at this point, my conclusion after reviewing vast amounts of literature, sorting out the propaganda from reality, is that the Covid vaccines are likely worthless for their stated purpose, and are unacceptably toxic. 7. As yet, I do not have the same concerns about the influenza vaccinations, or RSV, and thus I support those. As we know flu shots are often not protective, but when they are, it is great. They certainly do not have the toxicity created by mRNA technology. 8. Getting the flu vaccine as close to Nov as you can prior to your departure the better, as it will provide coverage further into the early months of 2024."  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Covid-19 PCR test positive on 07Jan2022; Covid-19 PCR test positive on 07Jan2022; dose received 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Oct2021 (Lot number: EW0186) at the age of 64 years as dose 3 (booster), single, administered in arm left, administration date 08Feb2021 (Lot number: EN5318) as dose 2, single and administered in arm left, administration date 29Jan2021 (Lot number: EN5318) as dose 1, single for covid-19 immunisation. Relevant medical history included: "no" (unspecified if ongoing), notes: Known allergies: No. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 07Jan2022, outcome "not recovered" and all described as "Covid-19 PCR test positive on 07Jan2022"; IMMUNISATION (medically significant) with onset 07Jan2022, outcome "unknown", described as "dose received 3". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (07Jan2022) positive. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Additional information: It was unknown if the patient receives any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200028871 same patient, different vaccine dose/AE
Patient was given Prevnar and Pedvax, and PPD. Developed a fever over 104 degrees Fahrenheit.  Parents took child to Clinic and ER. Mother states chest xray was done and diagnosed with early pneumonia.  Child was given antibiotics and fever reducer medications.
4cm elliptical fashion localized left upper outer arm. 1-2 cm reddened area in ea. armpit. SOLUMEDROL IM & prednisone taper.
Lip swelling: On 4/16/21, my lips swelled mildly, and the surrounding skin became red and irritated but not itchy. Topical Benadryl ointment reduced the irritation, and both the swelling and irritation ended by 4/19/21.  Arm swelling: On 4/21/21, my left arm developed two raised swollen spots, about 1.5 inches in diameter, at the vaccine injection site. The swollen skin was firm and red, but not itchy or painful. One day later, the two swollen spots had merged into one larger spot about 3 by 2 inches in size.  By 4/28/21, the swelling had gradually decreased, but the skin remained firm and slightly raised through 5/12/21. From 5/12/21 to 5/14/21, I took 200 mg of ibuprofen three times per day. By 5/15/21, the arm returned to normal.  I received my second dose (Moderna lot 022C21A) on 5/11/21. It was injected into my right arm. As of 5/21/21, I have not had any swelling or irritation.
After the 2nd covid vaccine, within a week I developed vertigo/after receiving the 3rd shot same thing occurred.; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 06Oct2021 (Lot number: FE3590) at the age of 36 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Sulfa, reaction(s): "Allergy", notes: Known Allergies: Sulfa. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL0140), administration date: 19Dec2020, when the patient was 35 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EL1283, Location of injection: Arm Left), administration date: 08Jan2021, when the patient was 36 years old, for COVID-19 Immunization, reaction(s): "After the 2nd covid vaccine, within a week I developed vertigo.". The following information was reported: VERTIGO (non-serious) with onset 07Oct2021, outcome "not recovered", described as "After the 2nd covid vaccine, within a week I developed vertigo/after receiving the 3rd shot same thing occurred.". Therapeutic measures were not taken as a result of vertigo.  Additional information: After the second covid vaccine, within a week patient developed vertigo. She had no prior history of such. Now again, after receiving the third shot same thing occurred. This time however it came on within a day of receiving the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Left thigh swollen with "hive-like" rash that extended from knee cap to boxer brief line and around almost to back of leg, leg warm to touch.  Patient stated he felt like his leg "was on fire."
Pt recvd vax & lab eval showed hepatitis B surface antigemia; No further details were provided;
Started having skin tingling in left side above hip which turned to painful rash. Diagnosed with Shingles on 1/29/22. Prescribed Valtrex at Urgent Care.
Pt reports waking up at 3am with severe, disseminated flushing (over full body), having chills alternating with hot flashes, muscle aches and weakness. Patient also reports having the feeling that "the top of her head was going to blow off".  At the time patient reported incident to the pharmacy (around 10:30am on 10/1/19, severity of reaction had diminished substantially, and flushing was limited to injection site only)
3 x 3 cm area of redness and induration within 10 minutes of injection
Received vaccine on 7/31/2021 at 6pm. Started spotting 8/1/2021 mid-day; heavy flow by 11pm; heavier than typical periods; still spotting lightly on 8/4/21
I was hospitalized for sepsis.  The culture of the infection indicated that there was no known origin for the infection. I was hospitalized for 6 days and have since fully recovered.
This spontaneous report as received from a nurse practitioner refers to an unspecified amount of patients (ages not provided). The nurse practitioner stated that the patients had received their GARDASIL series for prophylaxis off-schedule on unspecified dates. Lot numbers were not provided. No adverse effects reported. Additional information has been requested.
After few minutes of receiving both injections, patient start with dizziness, stomach ache. Per Dr. note: Patient did not faint,  not loss bowel or bladder control. No injury occurred. No prior episodes of vasovagal response of vaccines. Family Hx: Mother syncopal episode after vaccine at 19y/o. Vitals 5:42pm: BP: 104/56; SpO2:99; HR:83. Patient was laid supine 15 minutes. 6:07pm: BP:108/66; SpO2: 97; HR: 83.  Sat up 15 minutes, and then stood. Patient tolerated drink/snack. Patient left clinic stable.
Fever and body aches occurred about 10 hours after I received the second dose  Fever ranged from 101.8 - 100.4 for about 24 hours   Treated with Tylenol 650mg every six hours for a total Of three doses
Since my shot I have not been able to feel muscles all over my body. There is little to know sensation unless I press as hard as I can. Lymphnodes have been in pain and swollen since the first or second day after the shot. Headaches on and off for a month now. And my anxiety has been like I'm in fight or flight mode all of my waking moments. Even when I'm falling asleep. I will wake up with panic attacks. My muscles can't take talking on the phone for longer than 5 minutes before I have to switch to my other arm because the previous arm is "dead" in the muscles and couldn't do it any longer. Blood pressure was in the 180-190's / the high 80's and sometimes even 90 being my bottom BP number. It has since gone down because of meditation.
Woke  at 3 am with severe myalgias, tachycardia, nausea and shortness of breath.  Went to get tylenol/ zofran but felt like I was going to vomit.  Went into the bathroom and sat down.  Woke up on the floor shaking.  Not sure how long I was down.  According to my watch my HR was around 110+ for a hour and a half (3-4:30 am)
Within one week of receiving vaccine, experienced shortness of breath and chest tightness on exertion, lightheadedness, tachycardia.  Became increasing worse over next 5 days. Visit to ER on 1/18/21. Diagnosed with many bilateral pulmonary emboli with clots in both pulmonary arteries. Admitted to hospital and started on Eliquis. Had doppler on legs which showed DVT.
T106.2 R, tonic/clonic sz ensuing encephalopathy necessitating mechanical ventilation & hospitalization; 4DEC91 suspected mechanism: pertussis vax t106 febrile status epilepticus, hypoxic encephalopathy; f/u tone & head control dec;
The pt received the vax on 11/30/1998. On 7/14/99, the pt experienced excessive fatigue, joint pain, (most notable in wrists, ankles), intermittent dizziness and headaches. Arm went numb after each shot for 1/2 hour. 9/22/00 Received medical records which revealed dx of: pernicious anemia, Hashimotos thyroiditis, +ANA, Back & joint pain and swollen knuckles.
Grandmother came to clinic today 09/30/2014 said child got rash the day after the vaccines was administered. Generalized papular rash noted to include head and soles of feet.
During the 3 weeks after my Second Covid vaccination, I experienced all these symptoms repeatedly: Audio hallucinations Visual Hallucinations Extreme paranoia
On 1/11/21 developed itching, redness, hives to ears, neck, chest, trunk and arms.
Employee who received the COVID vaccine on 12/29 woke up the next day with a slight headache and rash at her injection site. As the day went by, her headache worsened.
The patient become sick to her stomach, pale, dizzy, clammy and slumped over in her chair.  It took an hour and a half for her to come somewhat back to her normal self and her color did not return until later that evening in the emergency room.